Timber Pharmaceuticals, Inc.(NYSE Amex Equities : TMBR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-1.43%||162.86||0.7%||$1035.04m|
|MRK||Merck & Co., Inc.||-0.68%||76.71||0.7%||$980.93m|
|LLY||Eli Lilly & Co.||-1.04%||219.89||1.1%||$902.80m|
|BMY||Bristol-Myers Squibb Co.||-0.38%||66.52||1.0%||$620.13m|
|ANVS||Annovis Bio, Inc.||4.53%||94.13||0.0%||$320.29m|
|BTX||Brooklyn ImmunoTherapeutics, Inc.||10.27%||16.92||12.4%||$104.76m|
|CNST||Constellation Pharmaceuticals, Inc.||-0.15%||33.77||0.0%||$104.68m|
Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.